23andMe Holding Co (ME)
4.75
+0.03
(+0.64%)
USD |
NASDAQ |
Nov 05, 16:00
4.72
-0.03
(-0.63%)
After-Hours: 19:08
23andMe Profit Margin (Quarterly): -171.7% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -171.7% |
| March 31, 2024 | -326.2% |
| December 31, 2023 | -621.2% |
| September 30, 2023 | -150.5% |
| June 30, 2023 | -171.9% |
| March 31, 2023 | -69.39% |
| December 31, 2022 | -137.4% |
| September 30, 2022 | -87.32% |
| June 30, 2022 | -138.8% |
| Date | Value |
|---|---|
| March 31, 2022 | -69.16% |
| December 31, 2021 | -157.1% |
| September 30, 2021 | -29.93% |
| June 30, 2021 | -70.94% |
| March 31, 2021 | -75.65% |
| December 31, 2020 | -80.47% |
| September 30, 2020 | -69.86% |
| June 30, 2020 | -74.43% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-621.2%
Minimum
Dec 2023
-29.93%
Maximum
Sep 2021
-147.2%
Average
-87.32%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
| RadNet Inc | -0.65% |
| iSpecimen Inc | -73.65% |
| Delcath Systems Inc | -176.9% |
| CytoSorbents Corp | -46.86% |
| Progyny Inc | 5.42% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -157.1% |
| Return on Assets | -103.7% |
| Return on Invested Capital | -157.1% |
| Gross Profit Margin (Quarterly) | 50.76% |
| Operating Margin (Quarterly) | -178.0% |
| Return on Net Operating Assets | -180.6% |